CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy 10% owner bought 1,000 shares at $2.80 ($2,800)
- 4 Open-market buy President, CEO, COB bought 4,200 shares at $2.44 ($10,248)
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 424B2 Offering Prospectus
- 8-K Event Other events
- 4 Open-market buy VP of Research and Development bought 747 shares at $3.56 ($2,659)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 4 Shares withheld for taxes VP of Research and Development gave up 6,729 shares (to pay taxes)
- 4 Shares withheld for taxes President, CEO, COB gave up 6,729 shares (to pay taxes)
- 4 Open-market buy 10% owner bought 6,200 shares at an average $2.86 ($17,705)
- 4 Shares withheld for taxes VP of Research and Development gave up 374 shares (to pay taxes)
- 4 Shares withheld for taxes President, CEO, COB gave up 374 shares (to pay taxes)
Page 8 of 38 · 755 filings